Literature DB >> 28419387

Effect of Continuous Positive Airway Pressure Treatment on Health-Related Quality of Life and Sleepiness in High Cardiovascular Risk Individuals With Sleep Apnea: Best Apnea Interventions for Research (BestAIR) Trial.

Ying Y Zhao1,2, Rui Wang1,2,3, Kevin J Gleason1,4, Eldrin F Lewis1,2,5, Stuart F Quan1,2, Claudia M Toth1,2, Michael Morrical1, Michael Rueschman1, Jia Weng1, James H Ware2,3, Murray A Mittleman2,6,7, Susan Redline1,2,6,7.   

Abstract

Study
Objectives: The long-term effect of continuous positive airway pressure (CPAP) on health-related quality of life (HRQOL) in patients with high cardiovascular disease risk and obstructive sleep apnea (OSA) without severe sleepiness is uncertain. We aimed to determine the effect of CPAP treatment on HRQOL in individuals with moderate or severe OSA and cardiovascular disease (CVD) or multiple CVD risk factors without severe sleepiness.
Methods: In this randomized, controlled, parallel group study, 169 participants were assigned to treatment with CPAP or the control group (conservative medical therapy [CMT] or CMT with sham CPAP). Analyses were based on an intention-to-treat approach. Linear mixed effect models were fitted to compare the changes in the Medical Outcomes Study Short Form-36 (SF-36) and in subjective sleepiness (Epworth Sleepiness Scale [ESS]) between groups from baseline to the average of 6- and 12-month measurements.
Results: CPAP improved several domains of HRQOL including bodily pain (treatment effect 9.7 [95% confidence interval, CI 3.9 to 15.4]; p = .001), vitality (5.7 [95% CI 1.5 to 9.9]; p = .008), general health (8.2 [95% CI 3.7 to 12.7]; p < .001), physical functioning (5.5 [95% CI 1.1 to 10.0]; p = .016), and the physical health summary score (3.3 [95% CI 1.4 to 5.3]; p = .001). CPAP also resulted in less daytime sleepiness (mean change in ESS -1.0 point [95% CI -2.0 to -0.0]; p = .040). Conclusions: In patients with moderate-severe OSA at high risk of cardiovascular events and without severe sleepiness, CPAP improved daytime sleepiness and multiple domains of HRQOL over 6 to 12 months of follow-up, with the largest improvement observed for bodily pain. © Sleep Research Society 2017. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com.

Entities:  

Keywords:  CPAP; clinical trial; quality of life; sleep apnea; sleepiness.

Mesh:

Year:  2017        PMID: 28419387      PMCID: PMC5806548          DOI: 10.1093/sleep/zsx040

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  44 in total

1.  Role of snoring and daytime sleepiness in occupational accidents.

Authors:  E Lindberg; N Carter; T Gislason; C Janson
Journal:  Am J Respir Crit Care Med       Date:  2001-12-01       Impact factor: 21.405

Review 2.  Long-term consequences of chronic pain: mounting evidence for pain as a neurological disease and parallels with other chronic disease states.

Authors:  Perry G Fine
Journal:  Pain Med       Date:  2011-07       Impact factor: 3.750

Review 3.  Sleep apnea and cardiovascular disease: a bidirectional relationship.

Authors:  Takatoshi Kasai; John S Floras; T Douglas Bradley
Journal:  Circulation       Date:  2012-09-18       Impact factor: 29.690

4.  The Effect of Treatment of Obstructive Sleep Apnea on Glycemic Control in Type 2 Diabetes.

Authors:  Jonathan E Shaw; Naresh M Punjabi; Matthew T Naughton; Leslee Willes; Richard M Bergenstal; Peter A Cistulli; Greg R Fulcher; Glenn N Richards; Paul Z Zimmet
Journal:  Am J Respir Crit Care Med       Date:  2016-08-15       Impact factor: 21.405

5.  Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis.

Authors:  Sanjay R Patel; David P White; Atul Malhotra; Michael L Stanchina; Najib T Ayas
Journal:  Arch Intern Med       Date:  2003-03-10

6.  The association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander.

Authors:  J Terán-Santos; A Jiménez-Gómez; J Cordero-Guevara
Journal:  N Engl J Med       Date:  1999-03-18       Impact factor: 91.245

7.  Quality of life in obstructive sleep apnea: a systematic review of the literature.

Authors:  C A Moyer; S S Sonnad; S L Garetz; J I Helman; R D Chervin
Journal:  Sleep Med       Date:  2001-11       Impact factor: 3.492

8.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

9.  Clustering of cardiovascular disease risk factors and health-related quality of life among US adults.

Authors:  Chaoyang Li; Earl S Ford; Ali H Mokdad; Lina S Balluz; David W Brown; Wayne H Giles
Journal:  Value Health       Date:  2008-01-08       Impact factor: 5.725

10.  Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning.

Authors:  Terri E Weaver; Greg Maislin; David F Dinges; Thomas Bloxham; Charles F P George; Harly Greenberg; Gihan Kader; Mark Mahowald; Joel Younger; Allan I Pack
Journal:  Sleep       Date:  2007-06       Impact factor: 5.849

View more
  19 in total

1.  Treatment of Adult Obstructive Sleep Apnea With Positive Airway Pressure: An American Academy of Sleep Medicine Systematic Review, Meta-Analysis, and GRADE Assessment.

Authors:  Susheel P Patil; Indu A Ayappa; Sean M Caples; R Joh Kimoff; Sanjay R Patel; Christopher G Harrod
Journal:  J Clin Sleep Med       Date:  2019-02-15       Impact factor: 4.062

2.  The role of sham continuous positive airway pressure as a placebo in controlled trials: Best Apnea Interventions for Research Trial.

Authors:  Michelle L Reid; Kevin J Gleason; Jessie P Bakker; Rui Wang; Murray A Mittleman; Susan Redline
Journal:  Sleep       Date:  2019-08-01       Impact factor: 5.849

3.  Serum levels of NGAL and cystatin C as markers of early kidney dysfunction in patients with obstructive sleep apnea syndrome.

Authors:  Athanasios Voulgaris; Kostas Archontogeorgis; Evangelia Nena; Christina Tsigalou; Maria Xanthoudaki; Maria Kouratzi; Grigorios Tripsianis; Marios Froudarakis; Paschalis Steiropoulos
Journal:  Sleep Breath       Date:  2018-06-26       Impact factor: 2.816

4.  Random-effects meta-analysis of combined outcomes based on reconstructions of individual patient data.

Authors:  Yue Song; Feng Sun; Susan Redline; Rui Wang
Journal:  Res Synth Methods       Date:  2020-05-08       Impact factor: 5.273

5.  Might chronic opioid use impact sleep-disordered breathing and vice versa?

Authors:  Jeremy E Orr; Mark S Wallace; Atul Malhotra
Journal:  J Clin Sleep Med       Date:  2020-06-15       Impact factor: 4.062

6.  Associations Between Sleep Disturbance and Chronic Pain Intensity and Function: A Test of Direct and Indirect Pathways.

Authors:  Helen J Burgess; John W Burns; Asokumar Buvanendran; Rajnish Gupta; Melissa Chont; Mary Kennedy; Stephen Bruehl
Journal:  Clin J Pain       Date:  2019-07       Impact factor: 3.442

7.  Association between obstructive sleep apnea and non-alcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Shanshan Jin; Suwen Jiang; Airong Hu
Journal:  Sleep Breath       Date:  2018-01-15       Impact factor: 2.816

Review 8.  Sleep Apnea and Cardiovascular Disease: Lessons From Recent Trials and Need for Team Science.

Authors:  Luciano F Drager; R Doug McEvoy; Ferran Barbe; Geraldo Lorenzi-Filho; Susan Redline
Journal:  Circulation       Date:  2017-11-07       Impact factor: 29.690

9.  Out of Center Sleep Testing in Ostensibly Healthy Middle Aged to Older Adults.

Authors:  Stuart F Quan; Brandon J Lockyer; Salma Batool-Anwar; Daniel Aeschbach
Journal:  Southwest J Pulm Crit Care       Date:  2019

10.  Prevalence of sleepiness and associations with quality of life in patients with sleep apnea in an online cohort.

Authors:  Lindsey J Wanberg; Rebecca E Rottapel; Michelle L Reid; Suzanne M Bertisch; Morgan Bron; Vishesh K Kapur; Shay Bujanover; Zinta Harrington; Jessie P Bakker; Sogol Javaheri; Mark Hanson; Kathleen Figetakis; Kathy Page; Sherry Hanes; Kathleen F Villa; Susan Redline
Journal:  J Clin Sleep Med       Date:  2021-12-01       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.